Navigation Links
Almac Successfully Moves its Clinical Technologies Business Unit Into New North American Headquarters
Date:10/13/2010

mg src="http://content.prnewswire.com/designimages/spacer_PRN.gif" border="0" height="1" width="1" alt="" /> Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Corporate Expansion Click to view news release full screen  

Almac Successfully Moves its Clinical Technologies Business Unit Into New North American Headquarters

 

SOUDERTON, Pennsylvania, October 13, 2010 /PRNewswire/ -- Almac announced today that its Clinical Technologies division has successfully moved into the Almac Group's new North American Headquarters. After groundbreaking of the 40-acre site in Souderton, PA on 23 July 2008, the drug development firm has now completed the first phase of relocating employees from three Almac business units to the new 240,000 square feet state-of-the-art integrated drug development facility.

On 11 October, Almac's technology bus
'/>"/>

SOURCE Almac Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Intelligroup Secures Multi-Million Dollar COSMOS Implementation with Almac Clinical Services
2. Aeterna Zentaris Announces Collaboration with Almac to Develop Therapy and Companion Diagnostic in Cancer
3. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
4. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
5. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
6. Neptune Technologies successfully completes $2.75 million private placement with 10% management participation
7. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
8. GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
9. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
10. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period
11. EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... San Diego, CA (PRWEB) December 17, 2014 ... strategy and activation agency and member of the Huntsworth ... Jamie Gonzales to its executive team. In her role, ... Services. , “We are incredibly honored to welcome ... said Agency Chief and CEO, Gaëtan Fraikin. “She is ...
(Date:12/17/2014)... FRANCISCO, Calif. , Dec. 17, 2014 /PRNewswire/ ... of a Phase 2 study evaluating the investigational ... treatment of patients with severe, chronic itch who ... standard of care, including topical steroids and antihistamines. ... percent change in Visual Analog Scale (VAS) itch ...
(Date:12/15/2014)... Organovo Holdings, Inc. (NYSE MKT: ONVO) ... breakthrough 3D bioprinting technology,  today celebrated continued positive ... exVive3D TM Human Liver Tissue.  The product, ... release on November 18, has been recognized as ... for innovation. Most recently, on December ...
(Date:12/13/2014)... December 13, 2014 CanDiag, Inc., a ... company has changed its name to OncoTab, Inc. ... of where we are today,” said CEO and Chief ... platform’s applications beyond breast cancer diagnostics to include imaging ... of that evolution.” , Founded in 2011 by Dr. ...
Breaking Biology Technology:Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... Dec. 1 Collexis Holdings, Inc.,(OTC Bulletin ... search and,knowledge discovery software, announced today a ... to promote BiomedExperts.com,to the association,s 200+ membership ... the primary professional network for,BioFlorida, helping to ...
... ISIS ) announces the following webcast: , , ... of a, microRNA, ... 1, 2008, at 8:30 a.m. ET / 5:30 a.m. PT, Where: ... Simply log onto our website listed above., , ...
... a California company aided in the research of vein treatment methods led ... equipment to develop a new medical device, which he will present this ... ... (PRWEB) December 1, 2008-- A gift from a California company aided in ...
Cached Biology Technology:BioFlorida Selects Collexis' BiomedExperts.com as the Primary Professional Network for its 200 Member Companies and Organizations 2BioFlorida Selects Collexis' BiomedExperts.com as the Primary Professional Network for its 200 Member Companies and Organizations 3BioFlorida Selects Collexis' BiomedExperts.com as the Primary Professional Network for its 200 Member Companies and Organizations 4Gift Aids Professor's Research into Vein Treatment 2Gift Aids Professor's Research into Vein Treatment 3Gift Aids Professor's Research into Vein Treatment 4
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
(Date:12/10/2014)... Dec. 9, 2014  Valencell, a leader in performance ... a staggering demand from its licensees for highly accurate, ... is not solely coming from fitness and health sectors, ... "A wearable is only as useful as the ... the ultimate driver in long-term mass consumer adoption of ...
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... peak supercomputer at the Department of Energy,s Pacific Northwest ... research in areas such as energy storage and future ... similar computers because of its unique water cooling system. ... about 20,000 typical personal computers combined, the Olympus supercomputer ...
... 2012 BGI, the world,s largest genomics organization, announced today ... for Soybean Biotechnology at the University of Missouri to ... contract in 2012 to re-sequence the first 100 lines ... agreement, BGI will provide library construction, re-sequencing analysis, 5X ...
... appears in toddlers just as they are beginning to walk ... energy-producing power plants of cells. This finding by a team ... and Hospital The Neuro- at McGill University, was published ... National Academy of Sciences of the USA ( PNAS ...
Cached Biology News:PNNL's Olympus supercomputer advances science, saves energy 2PNNL's Olympus supercomputer advances science, saves energy 3BGI enters agreement with National Center for Soybean Biotechnology to re-sequence 1,008 soybean lines 2BGI enters agreement with National Center for Soybean Biotechnology to re-sequence 1,008 soybean lines 3Defective cell 'battery' plays central role in neurodegenerative disease 2
... serum is extensively scrutinized, including ... All horses are of ... worming are controlled and documented ... consistency. Pricing: $12/unit ...
... new primer sets added in Dec 2005 ... hours , Detection from as little ... Specific primers available for hundreds of mammalian ... or end-point RT-PCR , Ideal for ...
jub, ajuba homolog (Xenopus laevis)...
Recommend to use at up to 5000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
Biology Products: